Risk of Immune Thrombocytopenic Purpura Recurrence Following Second Measles-Containing Vaccine Dose

Affiliations

¹ Kaiser Permanente Northern California, Division of Research, Vaccine Study Center, Oakland, California.
² Kaiser Permanente Washington Health Research Institute, Seattle, Washington.
³ Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado.
⁴ The Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon.
⁵ Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California.
⁶ HealthPartners Institute, Minneapolis, Minnesota.
⁷ Ambulatory Care Services, Denver Health, Denver, Colorado.
⁸ Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin.

Ousseny Zerbo et al. Pediatrics. 2025.

. 2025 Aug 1;156(2):e2025070931.

doi: 10.1542/peds.2025-070931.

¹ Kaiser Permanente Northern California, Division of Research, Vaccine Study Center, Oakland, California.
² Kaiser Permanente Washington Health Research Institute, Seattle, Washington.
³ Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado.
⁴ The Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon.
⁵ Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California.
⁶ HealthPartners Institute, Minneapolis, Minnesota.
⁷ Ambulatory Care Services, Denver Health, Denver, Colorado.
⁸ Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin.

No abstract available

LinkOut - more resources